Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMFS-202-302 for Cognitive Enhancement in Schizophrenia
NCT02237235Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Aug 2014
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Magnesium L-threonate in schizophrenia, schizoaffective disorder, sponsored by Northwestern University. Started Aug 2014; status: completed.
02
Drugs
Magnesium L-threonate
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02237235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237235.